Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Immune changes and specific genes contribute to male hair loss.

Fetal skin has unique immune cells different from adult skin.

JAK inhibitors might help treat alopecia areata.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Lung immune cells can be trained to better fight infections after a virus.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

IL-17 and certain immune cells are linked to more severe alopecia areata.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Developing human skin has immune cells with memory-like features.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

γδ T cells adapt uniquely to different tissues in mice.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Clonally expanded CD8+ T cells cause alopecia areata.